SCHEMBL7669190

SCHEMBL7669190

CCCCCC[N+]([O-])=Cc1ccc(S(=O)(=O)NC)o1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.34
TP53 P04637 1/20 0.34
ALDH1A1 P00352 3/20 0.33
GAA P10253 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
HTT P42858 2/20 0.32
LMNA P02545 1/20 0.32
MAPK1 P28482 1/20 0.32
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA3 P07451 1/20 0.31
CA4 P22748 1/20 0.31
CA6 P23280 1/20 0.31
CA5A P35218 1/20 0.31
CA7 P43166 1/20 0.31
CA9 Q16790 1/20 0.31
CA13 Q8N1Q1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7669753 0.90 CA12 (0.33) GAASMN1; SMN2MEN1KMT2AHTT
SCHEMBL7665533 0.85 CA1 (0.39) MAPTTP53ALDH1A1GAASMN1; SMN2
SCHEMBL7667410 0.84 CA12 (0.35) MAPTALDH1A1GAASMN1; SMN2MEN1
SCHEMBL7662784 0.79 CA1 (0.40) MAPTTP53ALDH1A1SMN1; SMN2MEN1
SCHEMBL7669454 0.78 ALDH1A1 (0.30) ALDH1A1
SCHEMBL7660817 0.73 CA1 (0.42) MEN1KMT2ACA1CA2
SCHEMBL7671014 0.73 ALDH1A1 (0.36) MAPTALDH1A1GAASMN1; SMN2MEN1
SCHEMBL7662605 0.72 LMNA (0.30) LMNA
SCHEMBL7658917 0.68 CASP6 (0.42) ALDH1A1CA12CA1CA2CA3
SCHEMBL7664533 0.68 ALDH1A1 (0.32) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6376540-B1 PREVENT NEURODEGENERATIVE DISEASE CENTAUR PHARMACEUTICALS, INC. 2002-04-23 US disclosed
US-6051571-A NERVOUS SYSTEM DISORDERS; CARDIOVASCULAR DISORDERS CENTAUR PHARMACEUTICALS, INC. (US) 2000-04-18 US disclosed
US-6040444-A Process for preparing furan nitrone compounds CENTAUR PHARMACEUTICALS, INC. (US) 2000-03-21 US disclosed